---
figid: PMC6295143__nihms-1515651-f0002
figlink: /pmc/articles/PMC6295143/figure/F2/
number: Figure 2
caption: TREM2 molecular signaling in microglia, initiating phagocytosis and microglial
  survival or modulating proinflammatory response, is not well characterized so only
  validated components are displayed. In vitro studies have suggested possible ligands
  for TREM2, which bind TREM2 to initiate signaling. TREM2 associates with DAP12,
  which is phosphorylated to activate signaling through recruitment of spleen tyrosine
  kinase (Syk). Syk activates the Ras/extracellular signal-regulated kinase (ERK)/protein
  kinase C (PKC) pathway to initiate phagocytosis. Microglial survival is initiated
  by the activation of the phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian target
  of rapamycin complex 1 (mTORC1) pathway. TREM2 is thought to influence inflammatory
  response by inhibiting the c-Jun N-terminal kinase (JNK) pathway which can be activated
  when ligands like lipopolysaccharide (LPS) bind toll-like receptor-4 (TLR4), initiating
  the production of proinflammatory cytokines.
pmcid: PMC6295143
papertitle: 'Triggering receptor expressed on myeloid cells 2 (TREM2): a potential
  therapeutic target for Alzheimer disease?.'
reftext: Yuetiva Deming, et al. Expert Opin Ther Targets. 2018 Jul;22(7):587-598.
pmc_ranked_result_index: '4730'
pathway_score: 0.952438
filename: nihms-1515651-f0002.jpg
figtitle: TREM2 molecular signaling in microglia, initiating phagocytosis and microglial
  survival or modulating proinflammatory response, is not well characterized so only
  validated components are displayed
year: '2018'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6295143__nihms-1515651-f0002.html
  '@type': Dataset
  description: TREM2 molecular signaling in microglia, initiating phagocytosis and
    microglial survival or modulating proinflammatory response, is not well characterized
    so only validated components are displayed. In vitro studies have suggested possible
    ligands for TREM2, which bind TREM2 to initiate signaling. TREM2 associates with
    DAP12, which is phosphorylated to activate signaling through recruitment of spleen
    tyrosine kinase (Syk). Syk activates the Ras/extracellular signal-regulated kinase
    (ERK)/protein kinase C (PKC) pathway to initiate phagocytosis. Microglial survival
    is initiated by the activation of the phosphatidylinositol-3-kinase (PI3K)/AKT/mammalian
    target of rapamycin complex 1 (mTORC1) pathway. TREM2 is thought to influence
    inflammatory response by inhibiting the c-Jun N-terminal kinase (JNK) pathway
    which can be activated when ligands like lipopolysaccharide (LPS) bind toll-like
    receptor-4 (TLR4), initiating the production of proinflammatory cytokines.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R6
  - PIK3R4
  - PIK3R5
  - AKT2
  - APOA1
  - PIK3CA
  - AKT1
  - PIK3CB
  - AKT3
  - TYROBP
  - HSPD1
  - RPTOR
  - MTOR
  - TREM2
  - APOE
  - APOA4
  - APOA5
  - APOA2
  - PIK3R3
  - IRF6
  - PIK3CG
  - MAPK9
  - PIK3CD
  - MAPK8
  - MAPK10
  - SYK
  - TLR4
  - LPS
genes:
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: phospholipids,apolipoproteins,
  symbol: Apolipoprotein
  source: bioentities_symbol
  hgnc_symbol: APOA1
  entrez: '335'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: DAP12
  symbol: DAP12
  source: hgnc_alias_symbol
  hgnc_symbol: TYROBP
  entrez: '7305'
- word: HSP60
  symbol: HSP60
  source: hgnc_alias_symbol
  hgnc_symbol: HSPD1
  entrez: '3329'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: RPTOR
  entrez: '57521'
- word: MTORC1
  symbol: mTORC1
  source: bioentities_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: TREM2
  symbol: TREM2
  source: hgnc_symbol
  hgnc_symbol: TREM2
  entrez: '54209'
- word: phospholipids,apolipoproteins,
  symbol: Apolipoprotein
  source: bioentities_symbol
  hgnc_symbol: APOE
  entrez: '348'
- word: phospholipids,apolipoproteins,
  symbol: Apolipoprotein
  source: bioentities_symbol
  hgnc_symbol: APOA4
  entrez: '337'
- word: phospholipids,apolipoproteins,
  symbol: Apolipoprotein
  source: bioentities_symbol
  hgnc_symbol: APOA5
  entrez: '116519'
- word: phospholipids,apolipoproteins,
  symbol: Apolipoprotein
  source: bioentities_symbol
  hgnc_symbol: APOA2
  entrez: '336'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: LPS
  symbol: LPS
  source: hgnc_prev_symbol
  hgnc_symbol: IRF6
  entrez: '3664'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: Syk
  symbol: SYK
  source: hgnc_symbol
  hgnc_symbol: SYK
  entrez: '6850'
- word: TLR4
  symbol: TLR4
  source: hgnc_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
chemicals: []
diseases:
- word: LPS
  source: MESH
  identifier: C536528
---
